| Title |
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings
|
|---|---|
| Published in |
Blood Advances, December 2019
|
| DOI | 10.1182/bloodadvances.2019000883 |
| Pubmed ID | |
| Authors |
Ann T Farrell, Julie Panepinto, Ankit A Desai, Adetola A Kassim, Jeffrey Lebensburger, Mark C Walters, Daniel E Bauer, Rae M Blaylark, Donna M DiMichele, Mark T Gladwin, Nancy S Green, Kathryn Hassell, Gregory J Kato, Elizabeth S Klings, Donald B Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T McGann, Caterina Minniti, Claudia R Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 108 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 13 | 12% |
| Other | 11 | 10% |
| Researcher | 11 | 10% |
| Student > Master | 5 | 5% |
| Student > Ph. D. Student | 4 | 4% |
| Other | 14 | 13% |
| Unknown | 50 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 31% |
| Biochemistry, Genetics and Molecular Biology | 8 | 7% |
| Nursing and Health Professions | 5 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Immunology and Microbiology | 2 | 2% |
| Other | 6 | 6% |
| Unknown | 50 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2023.
All research outputs
#6,786,775
of 23,907,431 outputs
Outputs from Blood Advances
#1,258
of 2,829 outputs
Outputs of similar age
#143,825
of 462,987 outputs
Outputs of similar age from Blood Advances
#35
of 114 outputs
Altmetric has tracked 23,907,431 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 2,829 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,987 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.